Current Report Filing (8-k)
April 21 2022 - 8:12AM
Edgar (US Regulatory)
HUMANA INC false 0000049071 0000049071 2022-04-21 2022-04-21
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): April 21, 2022 (April 21, 2022)
Humana Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
Delaware |
|
001-5975 |
|
61-0647538 |
(State or Other Jurisdiction of Incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
500 W. Main Street, Louisville, Kentucky 40202
(Address of Principal Executive Offices, and Zip Code)
(502) 580-1000
Registrant’s Telephone Number, Including Area Code
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
☐ |
Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
☐ |
Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Securities registered pursuant to Section 12(b) of the Act: |
|
|
|
|
|
Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
Common Stock |
|
HUM |
|
New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 |
Regulation FD Disclosure. |
On April 21, 2022, Humana Inc. announced it has signed a definitive agreement to divest a majority interest in its Kindred at Home Hospice and Personal Care divisions. A copy of Humana’s press release is being furnished as Exhibit 99.1 to this Form 8-K.
Item 9.01 |
Financial Statements and Exhibits. |
|
|
|
Exhibit No. |
|
Description |
|
|
99.1 |
|
Press Release |
|
|
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
HUMANA INC. |
|
|
BY: |
|
/s/ Michael A. Koeberlein |
|
|
Michael A. Koeberlein |
|
|
Senior Vice President, Chief Accounting Officer and Controller (Principal Accounting Officer) |
Dated: April 21, 2022
Humana (NYSE:HUM)
Historical Stock Chart
From Jul 2024 to Aug 2024
Humana (NYSE:HUM)
Historical Stock Chart
From Aug 2023 to Aug 2024